Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 0 | $0 |
| Sells | 9 | $363,141 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 05 Feb 2025 16:02 | ABUS | Arbutus Biopharma Corp | HASTINGS DAVID C | Chief Financial Officer | 04 Feb 2025 | Sale | 22,183 | 3.283 | 72,827 | D |
| 05 Feb 2025 16:02 | ABUS | Arbutus Biopharma Corp | SIMS KAREN | Chief Medical Officer | 04 Feb 2025 | Sale | 19,348 | 3.283 | 63,519 | D |
| 05 Feb 2025 16:02 | ABUS | Arbutus Biopharma Corp | MCELHAUGH MICHAEL J. | Interim President & CEO | 04 Feb 2025 | Sale | 23,790 | 3.283 | 78,103 | D |
| 05 Feb 2025 16:02 | ABUS | Arbutus Biopharma Corp | NAFTZGER J. CHRISTOPHER | General Counsel and CCO | 04 Feb 2025 | Sale | 11,333 | 3.283 | 37,206 | D |
| 16 Aug 2024 16:07 | ABUS | Arbutus Biopharma Corp | MANCHESTER KEITH S | Director | 14 Aug 2024 | Sale | 8,846 | 3.6895 | 32,637 | D |
| 05 Feb 2024 19:55 | ABUS | Arbutus Biopharma Corp | SIMS KAREN | Chief Medical Officer | 02 Feb 2024 | Sale | 4,358 | 2.3125 | 10,078 | D |
| 05 Feb 2024 19:54 | ABUS | Arbutus Biopharma Corp | HASTINGS DAVID C | Chief Financial Officer | 02 Feb 2024 | Sale | 9,593 | 2.3125 | 22,184 | D |
| 05 Feb 2024 19:54 | ABUS | Arbutus Biopharma Corp | SOFIA MICHAEL J. | Chief Scientific Officer | 02 Feb 2024 | Sale | 9,982 | 2.3125 | 23,083 | D |
| 05 Feb 2024 19:54 | ABUS | Arbutus Biopharma Corp | MCELHAUGH MICHAEL J. | Interim President & CEO | 02 Feb 2024 | Sale | 10,164 | 2.3125 | 23,504 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)